Phelan M J, Higginbotham E J
W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, USA.
Ophthalmic Surg Lasers. 1995 Sep-Oct;26(5):401-3.
Nd:YAG contact transscleral laser cyclophotocoagulation (CTLC) has been used in the treatment of adult glaucoma patients. However, little information is available regarding the use of this modality in pediatric glaucoma.
We retrospectively studied 10 pediatric patients (ages 8 months to 13 years) treated with Nd:YAG CTLC for refractory glaucoma. All patients were treated using our standard technique in an outpatient setting. Average treatment energy was 190.5 +/- 35.0 J.
The overall result was an average intraocular pressure (IOP) reduction of 48% +/- 6%. An IOP of less than 21 mm Hg was achieved in five patients (50%), and the average follow up was 15.5 +/- 5 months. Retreatment was required in 7 of 10 eyes. Loss of vision was seen in four patients, and one case of phthisis bulbi was noted.
Nd:YAG CTLC effectively lowers IOP in refractory pediatric glaucoma.
钕：钇铝石榴石接触式经巩膜激光睫状体光凝术（CTLC）已用于治疗成年青光眼患者。然而，关于该方法在儿童青光眼中的应用，可用信息甚少。
我们回顾性研究了10例接受钕：钇铝石榴石CTLC治疗难治性青光眼的儿科患者（年龄8个月至13岁）。所有患者均在门诊采用我们的标准技术进行治疗。平均治疗能量为190.5±35.0焦耳。
总体结果是平均眼压（IOP）降低了48%±6%。5例患者（50%）眼压降至21毫米汞柱以下，平均随访时间为15.5±5个月。10只眼中有7只需要再次治疗。4例患者出现视力丧失，并有1例眼球痨病例。
钕：钇铝石榴石CTLC可有效降低难治性儿童青光眼的眼压。
